INOV vs. QXO, YY, BCOV, ADEX, LTRPA, LIFW, LYT, NHIQ, NH, and WEJOF
Should you be buying Inovalon stock or one of its competitors? The main competitors of Inovalon include QXO (QXO), JOYY (YY), Brightcove (BCOV), Adit EdTech Acquisition (ADEX), Liberty TripAdvisor (LTRPA), MSP Recovery (LIFW), Lytus Technologies Holdings PTV. (LYT), NantHealth (NHIQ), NantHealth (NH), and Wejo Group (WEJOF).
Inovalon vs. Its Competitors
Inovalon (NASDAQ:INOV) and QXO (NASDAQ:QXO) are both data processing & preparation industry companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.
In the previous week, QXO had 14 more articles in the media than Inovalon. MarketBeat recorded 14 mentions for QXO and 0 mentions for Inovalon. QXO's average media sentiment score of 0.95 beat Inovalon's score of 0.00 indicating that QXO is being referred to more favorably in the news media.
QXO has a net margin of 30.08% compared to Inovalon's net margin of 6.73%. Inovalon's return on equity of 10.97% beat QXO's return on equity.
33.2% of Inovalon shares are held by institutional investors. Comparatively, 58.7% of QXO shares are held by institutional investors. 49.8% of Inovalon shares are held by company insiders. Comparatively, 51.3% of QXO shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
QXO has a consensus price target of $33.25, suggesting a potential upside of 53.23%. Given QXO's stronger consensus rating and higher probable upside, analysts clearly believe QXO is more favorable than Inovalon.
Inovalon has higher revenue and earnings than QXO. QXO is trading at a lower price-to-earnings ratio than Inovalon, indicating that it is currently the more affordable of the two stocks.
Inovalon has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Comparatively, QXO has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500.
Summary
QXO beats Inovalon on 11 of the 17 factors compared between the two stocks.
Get Inovalon News Delivered to You Automatically
Sign up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inovalon Competitors List
Related Companies and Tools
This page (NASDAQ:INOV) was last updated on 7/8/2025 by MarketBeat.com Staff
Free INOV Stock Alerts